1-1 of 1
Jg Piza, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Trial Comparison of Once Versus Twice Weekly Bortezomib in CYBORD Chemotherapy for Newly Diagnosed Myeloma: Identical High Response Rates and Less Toxicity.

Craig B. Reeder, MD, Donna E. Reece, Vishal Kukreti, MD, FRCPC, Joseph R. Mikhael, MD, Christine Chen, MD, Suzanne Trudel, MD, Kristina Laumann, Joseph Hentz, Nick Pirooz, Jg Piza, MD, Victor J Jimenez Zepeda, Rafael Fonseca, P. Leif Bergsagel, Jose Leis, Rodger E. Tiedemann, MBChB, PhD, FRACP, FRCPA, A. Keith Stewart, MBChB
Journal: Blood
Blood (2009) 114 (22): 616.
https://doi.org/10.1182/blood.V114.22.616.616
Published: 2009